跳转至内容
Merck
  • Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.

Relationship between the severity of acne vulgaris and antimicrobial resistance of bacteria isolated from acne lesions in a hospital in Japan.

Journal of medical microbiology (2014-02-14)
Keisuke Nakase, Hidemasa Nakaminami, Yuko Takenaka, Nobukazu Hayashi, Makoto Kawashima, Norihisa Noguchi
摘要

Propionibacterium acnes and Staphylococcus epidermidis are normal skin inhabitants that are frequently isolated from lesions caused by acne, and these micro-organisms are considered to contribute to the inflammation of acne. In the present study, we examined the antimicrobial susceptibilities and resistance mechanisms of P. acnes and S. epidermidis isolated from patients with acne vulgaris in a university hospital in Japan from 2009 to 2010. Additionally, we analysed the relationship between the antimicrobial resistance of P. acnes and the severity of acne vulgaris. Some P. acnes strains (18.8 %; 13/69) were resistant to clindamycin. All strains had a mutation in the 23S rRNA gene, except for one strain that expressed erm(X) encoding a 23S rRNA methylase. Tetracycline-resistant P. acnes strains were found to represent 4.3 % (3/69) of the strains, and this resistance was caused by a mutation in the 16S rRNA gene. Furthermore, three strains with reduced susceptibility to nadifloxacin (MIC = 16 µg ml(-1)) were detected. When analysing the correlation between the antimicrobial resistance of P. acnes and S. epidermidis, more than 80 % of the patients who carried clindamycin-resistant P. acnes also carried clindamycin-resistant S. epidermidis. However, no epidemic strain that exhibited antimicrobial resistance was detected in the P. acnes strains when analysed by PFGE. Therefore, our results suggest that the antimicrobial resistance of P. acnes is closely related to antimicrobial therapy. Additionally, those P. acnes strains tended to be frequently found in severe acne patients rather than in mild acne patients. Consequently, the data support a relationship between using antimicrobial agents and the emergence of antimicrobial resistance.

材料
货号
品牌
产品描述

Sigma-Aldrich
氯霉素,大包装, ≥98% (HPLC)
Sigma-Aldrich
红霉素, BioReagent, suitable for cell culture
Sigma-Aldrich
D -甘露醇, ≥98% (GC)
Sigma-Aldrich
米诺环素 盐酸盐, powder
Sigma-Aldrich
Levofloxacin, 98.0-102.0% anhydrous basis (HPLC)
Sigma-Aldrich
氯霉素,大包装, BioReagent, suitable for plant cell culture
Sigma-Aldrich
D -甘露醇, ≥98% (GC), suitable for plant cell culture
Supelco
盐酸环丙沙星, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D -甘露醇, ACS reagent
Supelco
甘露醇, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
克拉霉素, ≥95% (HPLC)
USP
甘露醇, United States Pharmacopeia (USP) Reference Standard
Supelco
克拉霉素, Pharmaceutical Secondary Standard; Certified Reference Material
USP
左氧氟沙星, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D -甘露醇, BioUltra, ≥99.0% (sum of enantiomers, HPLC)
USP
环丙沙星盐酸盐, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
红霉素, potency: ≥850 μg per mg
Sigma-Aldrich
D -甘露醇, BioXtra, ≥98% (HPLC)
Sigma-Aldrich
氯霉素,大包装, meets USP testing specifications
Supelco
红霉素, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
D -甘露醇, meets EP, FCC, USP testing specifications
Sigma-Aldrich
Erythromycin standard solution, 1 mg/mL in H2O
Sigma-Aldrich
克拉霉素, 96.0-102.0% (HPLC)